Abdullah Mohammed AlQwaee

Dr. Abdullah Mohammed AlQwaee


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2021 in Cureus
Verified
Journal Article
Open access
YBYasser A Bhat
Yasser A Bhat
AAAbdulrahman Almesned
Abdulrahman Almesned
AAAbdullah Mohammed AlQwaee
Abdullah Mohammed AlQwaee
AAAli Al Akhfash
Ali Al Akhfash
Transcatheter closure is the treatment of choice for most patent ductus arteriosus (PDA) in infants, children, and adults. However, there is a controversy regarding transcatheter closure of clinically silent PDAs. Some authors favor device closure to eliminate the lifelong risk of infective endarteritis while others recommend avoiding PDA closure in such patients. The study describes our experience of closing the silent PDAs using the Amplatzer duct occluder II-additional size (ADO II-AS) (St. Jude Medical Corp, St. Paul, MN). From April 2018 through March 2021, 52 consecutive pediatric patients aged 18 years and less with clinically silent PDA who had transcatheter closure at our center were enrolled. Patients were excluded if they had clinically detected PDAs; had surgical ligation of PDA with no residual shunt; had left heart dilatation on echocardiography; or moderate-sized PDAs closed with ADO II-AS. In addition, patients with an innocent murmur or murmur due to an associated lesion were included. This study was retrospective, and all of the 52 patients underwent PDA device closure using ADO II-AS. Fifty-two consecutive patients were enrolled with a median age of 17 months, range (97-2.5) 94.5 months. Mean weight was 11.29 kilogram, range (24.8-3.5) 21.3 kilogram, and mean follow-up was 13.5 months, range (29-0) 29 months. Thirty-one (59.6%) were females, and 21 (40.4%) were males. The mean procedure time was 30.6 min, range (60-10) 50 min, and mean fluoroscopic time was 5.5 min, range (28-1.7) 26.3 min. The mean volume of contrast given was 9.1 milliliter, range (30-4) 26 milliliter. Forty-five (45; 88.2%) patients had immediate closure of PDA. No patients had anesthetic or vascular complications; however, two patients had procedural complications. Device placement was unsuccessful in one patient with Downs syndrome. The mean follow-up for our patients was 13.5 months, range (29-0) 29 months; the patients were asymptomatic at the follow-up, and none of the patients had any residual leak. None of the patients showed coarctation or left pulmonary artery stenosis at the latest follow-up. The usefulness of catheter-based therapy for silent PDA is less well-established by current evidence. Further studies are needed to justify the intervention solely based on the premise that the silent duct is a substrate for infective endarteritis; however, our reason to close silent PDA was to do so primarily because of social reasons. This study found that device closure of silent PDA is safe and effective using an ADO II-AS device with minimal risk of embolization and a low residual shunt rate. Coils have been used to close small PDAs, however, with higher rates of embolization and device malpositioning. We believe ADO-II AS offers an advantage of safety and efficacy over coils. In addition, the study highlights the advantage of using an ADO II-AS device, which can be delivered via a four French delivery system with no arterial complications.

17 November 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
FAFatmah Fahad Alribdi
Fatmah Fahad Alribdi
MAMusaad Sulaiman Aljaloud
Musaad Sulaiman Aljaloud
AAAbdullah Mohammed AlQwaee
Abdullah Mohammed AlQwaee
AAABDULSALAM ِِALI ALFAWZAN
ABDULSALAM ِِALI ALFAWZAN
ACAnnalyn Velasquez Camba
Annalyn Velasquez Camba
MAMusa Mohammed Alharbi
Musa Mohammed Alharbi
Background: This study was conducted within the Qassim Health Cluster as part of efforts to operationalize the Saudi Model of Care (SMoC). It aims to evaluate the outcomes and value of palliative care services in alignment with SMoC by applying patient-centered measurement tools. In Saudi Arabia, Vision 2030 has spurred significant expansion in palliative care, yet challenges persist in home-based care and consistent outcome measurement. Current Quality-Adjusted Life Year (QALY) methodologies often fail to capture patient-centered dimensions (emotional, spiritual, and social support), leading to gaps in outcome assessments. Methods: This cross-sectional descriptive study characterized 147 oncology palliative care patients in Qassim, Saudi Arabia, from January to December 2024. Data on demographics, diagnoses, care duration, health-related quality of life (EQ-5D-5L), and patient experiences were collected via face-to-face interviews. Although QALY was conceptually referenced, the study utilized EQ-5D-5L as a proxy measure for patient-perceived health status. Results: The cohort was predominantly older females (64.63%) with various cancer diagnoses, primarily breast cancer (29.25%), and a long duration of palliative care. Patients reported significant impairments in mobility (21.77%), self-care, daily activities, and a high prevalence of pain and anxiety/depression. However, most felt respected by their care team (85.71%), experienced effective symptom management (68.03%), and were consistently involved in decision-making (68.03%). Conclusions: This study provides baseline data on oncology palliative care in Qassim, highlighting complex patient needs alongside positive perceptions of care. QALY methodologies must be refined to better capture patient-centered benefits and inform resource allocation, contributing to more responsive and effective palliative care services. However, due to the cross-sectional design, causal relationships between care exposure and outcomes cannot be inferred; hence, the findings should be interpreted as descriptive rather than causal.

5 June 2022 in Cureus
Verified
Journal Article
Open access
AAAreej Alotaibi
Areej Alotaibi
GAGhadir A Alakhfash
Ghadir A Alakhfash
AAAli Alakhfash
Ali Alakhfash
TMTayseer Mahmoud
Tayseer Mahmoud
AAAlhasan A Alakhfash
Alhasan A Alakhfash
AMAbdulrahman Mesned
Abdulrahman Mesned
This study aims to evaluate the value of Holter monitoring in pediatric cases and look for the best predictor for abnormal Holter monitoring. All patients referred with cardiac symptoms associated or possibly related to abnormal cardiac rhythm from January 2019 to December 2020 were retrospectively reviewed. The demographic, clinical, 12-lead electrocardiography (ECG), echocardiography, and Holter monitoring results were reviewed. Multinomial logistic regression analysis was used to assess the correlation between gender, age, type of symptoms, ECG, and echo abnormalities, and Holter monitoring results were analyzed. During the study period, a total of 189 Holter monitoring was performed for 187 patients. The mean age at the performance of Holter monitoring was 88.6 ± 57 months. The female/male ratio was 1.5:1. The commonest indications for Holter monitoring were abnormal 12-lead ECG (30.7%), palpitations (30.7%), syncopal attacks (12.7%), and chest pain (6.9%). Patients with congenital heart disease (CHD) pre- or post-cardiac intervention constitute 9% of the total Holter monitoring cases. Apart from sinus arrhythmia, 12-lead ECG was abnormal in 57 (30%) patients, with premature atrial complexes (PACs) being the most common abnormality. Echocardiography was abnormal in 67 (35.4%) cases, with secundum atrial septal defect (ASD) (6.3%) and mitral valve prolapse (5.8%) being the commonest abnormalities. The Holter monitoring was completely normal in 89 (47.1%) cases. The commonest Holter abnormalities were PACs (12.7%), supraventricular tachycardia (SVT) (5.8%), and premature ventricular complexes (PVCs) (4.8%). There were 24 patients with SVT, and eight of them had normal Holter monitoring. One patient with SVT had ablation by the electrophysiologist. Using the multinomial logistic regression analysis, significantly abnormal 12-lead ECG, the presence of CHD, and abnormal echocardiography predict the presence of abnormal Holter results with a statistically significant p-value. Most pediatric arrhythmias are benign. Holter monitoring provides reassurance for the patient and family. Abnormal Holter monitoring is more often observed in patients with paroxysmal or persistently abnormal 12-lead ECG with or without associated cardiac abnormalities or cardiac interventions. The yield of Holter monitoring is low in children referred because of chest pain, palpitations, or syncope with no other cardiac symptoms and with a structurally and functionally normal heart.

25 October 2022 in Cureus
Verified
Journal Article
Open access
AAAbdulkader M. Alsharif
Abdulkader M. Alsharif
YBYasser A Bhat
Yasser A Bhat
AMAbdulrahman Al Mesned
Abdulrahman Al Mesned
AAAbdullah Mohammed AlQwaee
Abdullah Mohammed AlQwaee
AAAli Al Akhfash
Ali Al Akhfash
This study aims to evaluate the radiation dose for transcatheter patent ductus arteriosus (PDA) via the arterial route and compare it with previously published benchmarks. Exposure to radiation in the catheterization lab can cause skin injury and cancer in the long run, especially in pediatric patients with complex heart conditions, which necessitate serial catheterizations. Therefore, measuring the patient radiation dose and establishing a benchmark for each cardiac interventional procedure is essential. In this prospective study, 34 patients with transcatheter patent ductus arteriosus closure via an arterial route were included. Patients who had silent PDAs, no left heart dilatation and PDA size of less than 2mm had PDA closed via an arterial route. All the study group patients received an Amplatzer duct occluder II-additional size device (St. Jude Medical Corp, St. Paul, MN) using biplane flat-panel fluoroscopy equipment adjusted in accordance with the pediatric parameters. Patients' dose area product, air kerma and fluoroscopy time were recorded in the catheterization lab and finally compared with internationally published reference data. Of 73 patients who had transcatheter patent ductus arteriosus closure between April 2021 to December 2021, 34 patients who had a PDA closure via an arterial route were enrolled. The median age and weight were 11.5 (4-168) months and 10.5 (6-31) kg. Twenty-one (61.8%) were males, and 13 (38.2%) were males. The median radiation dose parameters were as follows: air kerma 11 (3-42) milliGray, dose area product 131 (33-443) microGray per m2, median dose area product indexed to weight 12 (1-48) microGray m2 per kg, fluoroscopy time 2 (2-4) min and frame rate 15 (7.5-15) frames per second. Due to many factors, our radiation dose parameters were less than internationally published reference values for transcatheter PDA closure. Patient selection, detailed pre-catheterization echocardiography and procedure planning are essential for accomplishing device closure of PDA with a significant reduction in radiation dose. Hemodynamic assessment in the catheterization lab is unnecessary for most PDA patients. Additionally, a next-generation imaging platform equipped with flat-panel detectors and adjusted for pediatric settings and a fluoro recording option can be used to reduce radiation exposure.

30 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
FAFatmah Fahad Alribdi
Fatmah Fahad Alribdi
MAMusaad Sulaiman Aljaloud
Musaad Sulaiman Aljaloud
AAAbdullah Mohammed AlQwaee
Abdullah Mohammed AlQwaee
AAABDULSALAM ِِALI ALFAWZAN
ABDULSALAM ِِALI ALFAWZAN
ACAnnalyn Velasquez Camba
Annalyn Velasquez Camba
MAMusa Mohammed Alharbi
Musa Mohammed Alharbi
Background: This study was conducted within the Qassim Health Cluster as part of efforts to operationalize the Saudi Model of Care (SMoC). It aims to evaluate the outcomes and value of palliative care services in alignment with SMoC by applying patient-centered measurement tools. In Saudi Arabia, Vision 2030 has spurred significant expansion in palliative care, yet challenges persist in home-based care and consistent outcome measurement. Current Quality-Adjusted Life Year (QALY) methodologies often fail to capture patient-centred dimensions (emotional, spiritual, and social support), leading to gaps in outcome assessments. Methods: This cross-sectional descriptive study characterized 147 oncology palliative care patients in Qassim, Saudi Arabia, from January to December 2024. Data on demographics, diagnoses, care duration, health-related quality of life (EQ-5D-5L), and patient experiences were collected via face-to-face interviews. Although QALY was conceptually referenced, the study utilized EQ-5D-5L as a proxy measure for patient-perceived health status. Results: The cohort was predominantly older females (64.63%) with various cancer diagnoses, primarily breast cancer (29.25%), and a long duration of palliative care. Patients reported significant impairments in mobility (21.77%), self-care, daily activities, and a high prevalence of pain and anxiety/depression. However, most felt respected by their care team (85.71%), experienced effective symptom management (68.03%), and were consistently involved in decision-making (68.03%). Conclusion: This study provides baseline data on oncology palliative care in Qassim, highlighting complex patient needs alongside positive perceptions of care. QALY methodologies must be refined to better capture patient-centred benefits and inform resource allocation, contributing to more responsive and effective palliative care services.

13 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Mohammed Awad AlanaziMohammed Awad Alanazi
Mohammed Awad Alanazi
FAFatmah Fahad Alribdi
Fatmah Fahad Alribdi
AAAbdullah Mohammed AlQwaee
Abdullah Mohammed AlQwaee
ACAnnalyn Velasquez Camba
Annalyn Velasquez Camba
AAABDULSALAM ِِALI ALFAWZAN
ABDULSALAM ِِALI ALFAWZAN
KAKhuzama Alkhalaf
Khuzama Alkhalaf

Background: Hypertension is a major global risk factor for cardiovascular and non-communicable diseases (NCDs), with obesity and aging playing significant roles. While extensive national research has been conducted across Saudi Arabia, targeted studies specifically addressing urban centers like Buraidah remain scarce, necessitating region-specific evidence. Objective: To examine the impact of body mass index (BMI), age, Sex, and physical activity on blood pressure (BP) levels among adults in Buraidah. Methods: This cross-sectional study analyzed electronic medical records (EMRs) of 25,589 Saudi adults aged 18–65 years, collected between January and April 2024 from two urgent care centers. Participants with pre-existing hypertension, diabetes, cardiovascular disease, or dyslipidemia were excluded. The data included demographics, BMI, blood pressure (BP), and physical activity levels. We conducted statistical analyses including descriptive statistics, Pearson correlations, multiple linear regression, and subgroup analyses stratified by BMI category. Results: BMI and age were significantly associated with both systolic (SBP) and diastolic blood pressure (DBP). Notably, the impact of BMI on SBP was more pronounced among males. While physical activity showed a modest inverse relationship with DBP, it also had a smaller yet statistically significant association with SBP. Conclusion: Our study, the first of its kind in Buraidah, identified obesity and aging as key drivers of hypertension. These findings underscore the urgent need for targeted public health initiatives particularly in weight management, early screening, and gender-specific care, to support the Saudi Vision 2030’s healthcare objectives. Limitations include the cross-sectional design, which precludes causal inferences.